JP2018513180A5 - - Google Patents

Download PDF

Info

Publication number
JP2018513180A5
JP2018513180A5 JP2017555303A JP2017555303A JP2018513180A5 JP 2018513180 A5 JP2018513180 A5 JP 2018513180A5 JP 2017555303 A JP2017555303 A JP 2017555303A JP 2017555303 A JP2017555303 A JP 2017555303A JP 2018513180 A5 JP2018513180 A5 JP 2018513180A5
Authority
JP
Japan
Prior art keywords
independently selected
pharmaceutically acceptable
acceptable salt
compound according
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017555303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018513180A (ja
JP6777652B2 (ja
Filing date
Publication date
Priority claimed from GBGB1506894.3A external-priority patent/GB201506894D0/en
Application filed filed Critical
Publication of JP2018513180A publication Critical patent/JP2018513180A/ja
Publication of JP2018513180A5 publication Critical patent/JP2018513180A5/ja
Application granted granted Critical
Publication of JP6777652B2 publication Critical patent/JP6777652B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017555303A 2015-04-23 2016-04-19 炎症性障害の治療のための新規ジヒドロピリドイソキノリノン及びその医薬組成物 Active JP6777652B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1506894.3A GB201506894D0 (en) 2015-04-23 2015-04-23 Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB1506894.3 2015-04-23
PCT/EP2016/058607 WO2016169911A1 (en) 2015-04-23 2016-04-19 Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Publications (3)

Publication Number Publication Date
JP2018513180A JP2018513180A (ja) 2018-05-24
JP2018513180A5 true JP2018513180A5 (cg-RX-API-DMAC7.html) 2019-05-23
JP6777652B2 JP6777652B2 (ja) 2020-10-28

Family

ID=53488521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017555303A Active JP6777652B2 (ja) 2015-04-23 2016-04-19 炎症性障害の治療のための新規ジヒドロピリドイソキノリノン及びその医薬組成物

Country Status (19)

Country Link
US (1) US10568879B2 (cg-RX-API-DMAC7.html)
EP (1) EP3286191B1 (cg-RX-API-DMAC7.html)
JP (1) JP6777652B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170139142A (cg-RX-API-DMAC7.html)
CN (1) CN107531703B (cg-RX-API-DMAC7.html)
AR (1) AR104362A1 (cg-RX-API-DMAC7.html)
AU (1) AU2016251517A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017022008A2 (cg-RX-API-DMAC7.html)
CA (1) CA2983342A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017011093A2 (cg-RX-API-DMAC7.html)
GB (1) GB201506894D0 (cg-RX-API-DMAC7.html)
IL (1) IL255109A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017013382A (cg-RX-API-DMAC7.html)
PH (1) PH12017501911A1 (cg-RX-API-DMAC7.html)
RU (1) RU2017134551A (cg-RX-API-DMAC7.html)
SG (1) SG11201708671RA (cg-RX-API-DMAC7.html)
TW (1) TW201702243A (cg-RX-API-DMAC7.html)
WO (1) WO2016169911A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201706674B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3403649A1 (en) * 2017-05-16 2018-11-21 Bayer Pharma Aktiengesellschaft Inhibitors and antagonists of gpr84 for the treatment of endometriosis
CN106977483A (zh) * 2017-06-02 2017-07-25 遵义医学院 一种二氟烷基取代的黄酮醇、异黄酮醇和香豆素类化合物的合成方法
IL301709B2 (en) 2017-08-09 2025-07-01 Denali Therapeutics Inc Compounds, compositions and methods
TW201920129A (zh) 2017-09-01 2019-06-01 美商戴納立製藥公司 化合物、組合物及方法
US20210106582A1 (en) 2017-11-15 2021-04-15 Galapagos Nv Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
WO2020007342A1 (zh) * 2018-07-06 2020-01-09 中国科学院上海药物研究所 联苯磷酸酯类化合物作为gpr84拮抗剂的应用
EP3924341A4 (en) 2019-02-13 2022-11-02 Denali Therapeutics Inc. Compounds, compositions and methods
CR20210426A (es) * 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos
PH12022551509A1 (en) * 2019-12-19 2023-04-24 Bayer Ag Furoindazole derivatives
WO2021123394A1 (en) 2019-12-20 2021-06-24 University Of Copenhagen G protein-coupled receptor modulators and a pharmaceutical composition
TW202241857A (zh) 2020-12-18 2022-11-01 美商戴納立製藥公司 化合物之固體形式
KR20230153387A (ko) 2021-02-02 2023-11-06 리미널 바이오사이언시스 리미티드 Gpr84 길항제 및 이의 용도
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Gpr84アンタゴニストおよびその使用
WO2022179940A1 (en) 2021-02-23 2022-09-01 Bayer Aktiengesellschaft Furoindazole derivatives as gpr84 antagonists
WO2022218372A1 (zh) * 2021-04-14 2022-10-20 武汉人福创新药物研发中心有限公司 一种二氢嘧啶并异喹啉酮类衍生物及用途
WO2022229061A1 (en) 2021-04-29 2022-11-03 Bayer Aktiengesellschaft Furoindazole derivatives as antagonists or inhibitors of gpr84
WO2022263676A1 (en) 2021-06-18 2022-12-22 University Of Copenhagen Polysubstituted 4-hydroxypyridine and 4-hydroxyquinoline derivatives as gpr84 antagonists
CN115611944A (zh) 2021-07-15 2023-01-17 中国科学院上海药物研究所 不对称gpr84拮抗剂及其用途
WO2024083705A1 (en) 2022-10-18 2024-04-25 Bayer Aktiengesellschaft Furoindazole derivatives for the treatment of pain
USD1117011S1 (en) * 2024-07-10 2026-03-10 Delta Electronics, Inc. Charging connector
USD1119767S1 (en) * 2024-07-10 2026-03-24 Delta Electronics, Inc. Charging connector

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0926148A1 (en) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
WO2005050225A2 (en) * 2003-10-31 2005-06-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 84 (gpr84)
CA2621144A1 (en) 2005-09-02 2007-03-08 Arena Pharmaceuticals, Inc. Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression
EP2619203A4 (en) 2010-09-20 2014-04-16 Glaxo Group Ltd TRICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND APPLICATIONS THEREOF
AR089284A1 (es) * 2011-12-22 2014-08-13 Galapagos Nv Dihidropirimidinoisoquinolinonas y composiciones farmaceuticas de las mismas para el tratamiento de trastornos inflamatorios
JP6293784B2 (ja) 2012-12-20 2018-03-14 ガラパゴス・ナムローゼ・フェンノートシャップGalapagos N.V. 炎症性障害の治療のための新規ジヒドロピリミジノイソキノリノン及びその医薬組成物(gpr84アンタゴニスト)
GB201411241D0 (en) 2014-06-25 2014-08-06 Galapagos Nv Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Similar Documents

Publication Publication Date Title
JP6240164B2 (ja) ピロール誘導体の結晶及びその製造方法
JP6559324B2 (ja) B型肝炎ウイルス感染の治療及び予防用の新規6,7−ジヒドロピリド[2,1−a]フタラジン−2−オン類
JP6568106B2 (ja) B型肝炎ウイルス感染症の治療及び予防のための新規ジヒドロキノリジノン類
ES2292988T3 (es) Derivados de nicotinamida utiles como inhibidores de pde4.
JP5252404B2 (ja) ピラジン化合物、その使用及び調製方法
JP6777652B2 (ja) 炎症性障害の治療のための新規ジヒドロピリドイソキノリノン及びその医薬組成物
JP5373634B2 (ja) ムスカリンm3アンタゴニストのナパジシル酸塩
JP2020503288A (ja) 選択的ヤヌスキナーゼ阻害剤としてのアミノピラゾール類
JP6602902B2 (ja) 脾臓チロシンキナーゼi(syk)阻害剤としての2−(2−アミノシクロヘキシル)アミノピリミジン−5−カルボキサミド類
JP7798362B2 (ja) Bcl-2阻害剤としての化合物
WO2008008854A9 (en) Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders
JP2004509855A (ja) TNFαインヒビターとして有用なクマリン誘導体
JP2022526364A5 (cg-RX-API-DMAC7.html)
US9284320B2 (en) Ticagrelor adducts with divalent metal salts
JP2024032976A (ja) アデノシン受容体アンタゴニストおよびその使用
JP7013446B2 (ja) Gaba(a)受容体モジュレーター、及び、喘息における気道過敏及び炎症を抑制するための方法
US10766883B2 (en) Aminopyrazoles as janus kinase inhibitors
TW202000650A (zh) 4-甲基二氫嘧啶酮化合物及其醫藥用途
UA72017C2 (en) Tetrahydropyridines, a method for the preparation thereof and a pharmaceutical composition containing them
JP5960138B2 (ja) リン酸エステル誘導体
JP7193557B2 (ja) 新規な気管支拡張性ヘテロ結合アミド
JPH11292879A (ja) カルボキサミド誘導体
JP2011530588A (ja) 2−ヒドロキシ−エタンスルホン酸塩
JP2025534728A (ja) ジメチル-2,3-ジヒドロ-1h-インデン誘導体の改良された製造方法
CA2797350A1 (en) Co-crystal intermediates of rosuvastatin and methods of using same